Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading

Journal of Clinical Investigation

Volumn 110, Issue 5, 2002, Pages 701-710

  Wildbaum, Gizi ^a   Netzer, Nir ^a   Karin, Nathan ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; MYELIN BASIC PROTEIN; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENCEPHALOMYELITIS; FEMALE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0036732037     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215176     Document Type: Article

References (60)

1. Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease
2. Multiple sclerosis: A pivotal role for the T cell in lesion development
3. Functional evidence for epitope spreading in the relapsing pathology, of experimental autoimmune encephalomyelitis
4. T cell determinants of myelin basic protein include a unique encephalitogenic I-E-restricted epitope for Lewis rats
5. Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. I. T cell receptor peptide regulation of T cell clones expressing cross-reactive V beta genes
6. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
7. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis
8. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE
9. Definition of encephalitogenic and immunodominant epitopes of Guinea pig myelin basic protein (GpBP) in Lewis rats tolerized neonatally with Gp-BP or Gp-BP peptides
10. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein
11. Expansion of neonatal tolerance to self in adult life: I. The role of a bacterial adjuvant in tolerance spread
12. Expansion of neonatal tolerance to self in adult life: II. Tolerance preferentially spreads in an intramolecular manner
13. Identification of an N-terminally acetylated encephalitogenic epitope in myelin proteolipid apoprotein for the Lewis rat
14. Reversal of experimental autoimmune encephalomyelitis by as soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of IFN-g and TNF-a production
15. Short peptide based tolerogens without antigenic activity reverse autoimmunity
16. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
17. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease
18. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis
19. Role of cytokines in determining T-lymphocyte function
20. Functional diversity of helper T lymphocytes
21. IL-4 directs the development of Th2-like helper effectors
22. Cytokine transcriptional events during helper T cell subset differentiation
23. IL-12 acts directly on CD4+ T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming
24. The presence of interleukin-4 during in vitro priming determines the cytokine-producing potential of CD4+ T cells from T cell receptor cransgenic mice
25. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells
26. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
27. The role of IL-10 in the crossregulation of Th1 and Th2 responses
28. IL-4 and IL-13 production in differentiated T helper type 2 cells is not IL-4 dependent
29. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB
30. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
31. Prevention of experimental autoimmune encephalomyelitis by antibodies to interferon gamma inducing factor
32. Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis
33. Regulatory T-cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
34. Regulatory T cells in the control of autoimmunity: The essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC-cells and CD4(+)CD8(-) thymocytes
35. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
36. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
37. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
38. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes
39. CD4+ Cd25+ suppressor T cells: More questions than answers
40. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
41. A T cell epitope for experimental allergic neuritis
42. Long lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines
43. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis
44. Selective and nonselective stages in homing of T lymphocytes to the central nervous system during experimental allergic encephalomyelitis
45. Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-alpha) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis
46. A targeted DNA vaccine encoding Fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis
47. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations
48. Regulatory T cells in the control of immune pathology
49. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease
50. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells
51. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10
52. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice
53. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis
54. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: A role for IL-10
55. Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis
56. Transforming growth factor beta (TGF-beta)dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines
57. Immunoregulation of encephalitogenic MBP-NAc1-II-reactive T cells by CD4+ TCR-specific T cells involves IL-4, IL-10 and IFN-gamma
58. Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP-Ac1-11
59. Tolerization of dendritic cells by T(S) cells: The crucial role of inhibitory receptors ILT3 and ILT4
60. Regulatory T cells: Key controllers of immunologic self-tolerance